Annual EBITDA
$3.34B$196.00M-5.54%
Summary
- Current Value
- As of today, GEHC annual EBITDA is $3.34B, down -5.54% on
- Historical Performance
- GEHC annual EBITDA is up +4.47% over the past 3 years, down -0.30% over the past 5 years
- All-Time High Comparison
- GEHC annual EBITDA is currently -5.54% below its historical high of $3.54B set on
- 3-Year Low Comparison
- GEHC annual EBITDA is +4.47% above its 3-year low of $3.20B reached on an earlier date
- Sector Comparison
- GEHC annual EBITDA is higher than 96.63% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.34B | -5.5% | +4.5% | -0.3% | +20.0% | |
| Quarterly EBITDA | $974.00M | +15.1% | +34.9% | +10.6% | +10.6% | |
| TTM EBITDA | $3.66B | +5.4% | +19.7% | +315.1% | +315.1% | |
| Price | $76.57 | +2.1% | +21.2% | – | – | |
| PE Ratio | 16.18 | +4.3% | -13.8% | – | – | |
| Annual Revenue | $20.63B | +4.8% | +12.4% | +20.2% | +24.0% | |
| Annual EPS | $4.55 | +4.8% | +7.8% | +3.1% | +35.8% | |
| $2.76B | -6.6% | +7.7% | +1.5% | +30.0% | ||
| Annual Net Income | $2.15B | +5.1% | +10.5% | +4.7% | +28.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.54B | -5.5% | |
| 5Y | $3.54B | -5.5% | |
| All | $3.54B | -5.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.20B | N/A | +4.5% |
| 5Y | $3.20B | +4.5% | |
| All | $2.78B | +20.0% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $3.34B | -5.5% | |
| $3.54B | +4.1% | |
| $3.40B | +6.3% | |
| $3.20B | -6.5% |
| Year | Value | Change |
|---|---|---|
| $3.42B | +2.1% | |
| $3.35B | +20.4% | |
| $2.78B | - |
FAQ
- What is the current annual EBITDA of GEHC?
- As of today, GEHC annual EBITDA is $3.34B
- What is 1-year change in GEHC annual EBITDA?
- GEHC annual EBITDA is down -5.54% year-over-year
- What is 3-year change in GEHC annual EBITDA?
- GEHC annual EBITDA is up +4.47% over the past 3 years
- How far is GEHC annual EBITDA from its all-time high?
- GEHC annual EBITDA is currently -5.54% below its historical high of $3.54B set on December 31, 2024
- How does GEHC annual EBITDA rank versus sector peers?
- GEHC annual EBITDA is higher than 96.63% of companies in Healthcare sector
- When is GEHC next annual earnings release?
- The next annual earnings release for GEHC is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$974.00M$73.00M+8.10%
Summary
- Current Value
- As of today, GEHC quarterly EBITDA is $974.00M, up +8.10% on
- Historical Performance
- GEHC quarterly EBITDA is up +15.13% year-over-year, up +34.90% over the past 3 years
- All-Time High Comparison
- GEHC quarterly EBITDA is currently -6.88% below its historical high of $1.05B set on
- 3-Year Low Comparison
- GEHC quarterly EBITDA is +34.90% above its 3-year low of $722.00M reached on an earlier date
- Sector Comparison
- GEHC quarterly EBITDA is higher than 96.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $974.00M | +8.1% | +15.1% | +34.9% | +10.6% | |
| Annual EBITDA | $3.34B | – | -5.5% | +4.5% | -0.3% | |
| TTM EBITDA | $3.66B | +3.6% | +5.4% | +19.7% | +315.1% | |
| Price | $76.57 | +9.5% | +2.1% | +21.2% | – | |
| PE Ratio | 16.18 | +0.7% | +4.3% | -13.8% | – | |
| Quarterly Revenue | $5.51B | +4.1% | +7.2% | +14.3% | +20.1% | |
| Quarterly EPS | $1.36 | +9.9% | +39.1% | +65.8% | +9.4% | |
| $811.00M | +9.4% | +16.4% | +42.5% | +11.6% | ||
| Quarterly Net Income | $623.00M | +8.5% | +34.3% | +61.4% | +8.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.05B | -6.9% | |
| 3Y | $1.05B | -6.9% | |
| 5Y | $1.05B | -6.9% | |
| All | $1.05B | -6.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $736.00M | +32.3% | |
| 3Y | $722.00M | N/A | +34.9% |
| 5Y | $670.00M | +45.4% | |
| All | $670.00M | +45.4% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of GEHC?
- As of today, GEHC quarterly EBITDA is $974.00M
- What is GEHC quarterly EBITDA most recent change?
- GEHC quarterly EBITDA was up +8.10% on September 30, 2026
- What is 1-year change in GEHC quarterly EBITDA?
- GEHC quarterly EBITDA is up +15.13% year-over-year
- How far is GEHC quarterly EBITDA from its all-time high?
- GEHC quarterly EBITDA is currently -6.88% below its historical high of $1.05B set on December 31, 2025
- How does GEHC quarterly EBITDA rank versus sector peers?
- GEHC quarterly EBITDA is higher than 96.72% of companies in Healthcare sector
- When is GEHC next earnings release?
- The next earnings release for GEHC is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$3.66B$128.00M+3.63%
Summary
- Current Value
- As of today, GEHC TTM EBITDA is $3.66B, up +3.63% on
- Historical Performance
- GEHC TTM EBITDA is up +5.42% year-over-year, up +19.67% over the past 3 years
- All-Time High Comparison
- GEHC TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GEHC TTM EBITDA is +19.67% above its 3-year low of $3.06B reached on an earlier date
- Sector Comparison
- GEHC TTM EBITDA is higher than 96.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.66B | +3.6% | +5.4% | +19.7% | +315.1% | |
| Annual EBITDA | $3.34B | – | -5.5% | +4.5% | -0.3% | |
| Quarterly EBITDA | $974.00M | +8.1% | +15.1% | +34.9% | +10.6% | |
| Price | $76.57 | +9.5% | +2.1% | +21.2% | – | |
| PE Ratio | 16.18 | +0.7% | +4.3% | -13.8% | – | |
| TTM Revenue | $21.64B | +1.7% | +6.9% | +12.2% | +371.5% | |
| TTM EPS | $4.73 | +8.8% | -2.1% | +40.6% | +281.6% | |
| $3.04B | +3.9% | +4.8% | +24.7% | +317.5% | ||
| TTM Net Income | $2.21B | +7.8% | -3.5% | +24.9% | +283.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.66B | at high | |
| 3Y | $3.66B | at high | |
| 5Y | $3.66B | at high | |
| All | $3.66B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.40B | +7.5% | |
| 3Y | $3.06B | N/A | +19.7% |
| 5Y | $881.00M | +315.1% | |
| All | $881.00M | +315.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of GEHC?
- As of today, GEHC TTM EBITDA is $3.66B
- What is GEHC TTM EBITDA most recent change?
- GEHC TTM EBITDA was up +3.63% on September 30, 2026
- What is 1-year change in GEHC TTM EBITDA?
- GEHC TTM EBITDA is up +5.42% year-over-year
- How far is GEHC TTM EBITDA from its all-time high?
- GEHC TTM EBITDA is currently at its all-time high
- How does GEHC TTM EBITDA rank versus sector peers?
- GEHC TTM EBITDA is higher than 96.72% of companies in Healthcare sector
- When is GEHC next earnings release?
- The next earnings release for GEHC is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GEHC Official Website www.gehealthcare.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1932393/000193239326000007/0001932393-26-000007-index.htm
- GEHC Profile on Yahoo Finance finance.yahoo.com/quote/GEHC
- GEHC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gehc
